Previous close | 4,105.00 |
Open | 4,120.00 |
Bid | 4,164.00 x N/A |
Ask | 4,166.00 x N/A |
Day's range | 4,092.00 - 4,172.00 |
52-week range | 2,724.00 - 4,172.00 |
Volume | |
Avg. volume | 3,927 |
Market cap | 38.432B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 43.15 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 68.00 (1.66%) |
Ex-dividend date | 25 Mar 2024 |
1y target est | N/A |
BLANQUEFORT, France & VERNIER, Switzerland, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), today announced the signature of a definitive agreement with Givaudan, world leader in the creation of flavors and fragrances (ISIN code: CH0010645932 - Ticker: GIVN), concerning the acquisition of Naturex Iberian Partners (Givaudan's industrial site in Valencia - Spain).